401 related articles for article (PubMed ID: 26791049)
1. The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs).
Kidger AM; Keyse SM
Semin Cell Dev Biol; 2016 Feb; 50():125-32. PubMed ID: 26791049
[TBL] [Abstract][Full Text] [Related]
2. Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling.
Caunt CJ; Keyse SM
FEBS J; 2013 Jan; 280(2):489-504. PubMed ID: 22812510
[TBL] [Abstract][Full Text] [Related]
3. Visualizing and Quantitating the Spatiotemporal Regulation of Ras/ERK Signaling by Dual-Specificity Mitogen-Activated Protein Phosphatases (MKPs).
Caunt CJ; Kidger AM; Keyse SM
Methods Mol Biol; 2016; 1447():197-215. PubMed ID: 27514808
[TBL] [Abstract][Full Text] [Related]
4. Dual-specificity MAP kinase phosphatases (MKPs) and cancer.
Keyse SM
Cancer Metastasis Rev; 2008 Jun; 27(2):253-61. PubMed ID: 18330678
[TBL] [Abstract][Full Text] [Related]
5. Dual specific phosphatases (DUSPs) in cardiac hypertrophy and failure.
Mutlak M; Kehat I
Cell Signal; 2021 Aug; 84():110033. PubMed ID: 33933582
[TBL] [Abstract][Full Text] [Related]
6. Dual-specificity phosphatases: critical regulators with diverse cellular targets.
Patterson KI; Brummer T; O'Brien PM; Daly RJ
Biochem J; 2009 Mar; 418(3):475-89. PubMed ID: 19228121
[TBL] [Abstract][Full Text] [Related]
7. Dual specificity phosphatases 10 and 16 are positive regulators of EGF-stimulated ERK activity: indirect regulation of ERK signals by JNK/p38 selective MAPK phosphatases.
Finch AR; Caunt CJ; Perrett RM; Tsaneva-Atanasova K; McArdle CA
Cell Signal; 2012 May; 24(5):1002-11. PubMed ID: 22245064
[TBL] [Abstract][Full Text] [Related]
8. Dual-specificity MAP kinase phosphatases in health and disease.
Seternes OM; Kidger AM; Keyse SM
Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):124-143. PubMed ID: 30401534
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the kinase interaction motif in mitogen-activated protein (MAP) kinase phosphatase-4 mediates cross-talk between protein kinase A and MAP kinase signaling pathways.
Dickinson RJ; Delavaine L; Cejudo-Marín R; Stewart G; Staples CJ; Didmon MP; Trinidad AG; Alonso A; Pulido R; Keyse SM
J Biol Chem; 2011 Nov; 286(44):38018-38026. PubMed ID: 21908610
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.
Owens DM; Keyse SM
Oncogene; 2007 May; 26(22):3203-13. PubMed ID: 17496916
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal regulation of ERK2 by dual specificity phosphatases.
Caunt CJ; Armstrong SP; Rivers CA; Norman MR; McArdle CA
J Biol Chem; 2008 Sep; 283(39):26612-23. PubMed ID: 18650424
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of MAP kinase activation by a novel splice variant of human MAP kinase phosphatase-2.
Cadalbert LC; Sloss CM; Cunningham MR; Al-Mutairi M; McIntire A; Shipley J; Plevin R
Cell Signal; 2010 Mar; 22(3):357-65. PubMed ID: 19843478
[TBL] [Abstract][Full Text] [Related]
13. Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERK.
Peng DJ; Zhou JY; Wu GS
Cell Cycle; 2010 Dec; 9(23):4650-5. PubMed ID: 21084841
[TBL] [Abstract][Full Text] [Related]
14. Dual specificity phosphatase 5 and 6 are oppositely regulated in human skeletal muscle by acute exercise.
Pourteymour S; Hjorth M; Lee S; Holen T; Langleite TM; Jensen J; Birkeland KI; Drevon CA; Eckardt K
Physiol Rep; 2017 Oct; 5(19):. PubMed ID: 28989118
[TBL] [Abstract][Full Text] [Related]
15. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
[TBL] [Abstract][Full Text] [Related]
16. Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer.
Wu GS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):579-85. PubMed ID: 17717636
[TBL] [Abstract][Full Text] [Related]
17. Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expression.
Rushworth LK; Kidger AM; Delavaine L; Stewart G; van Schelven S; Davidson J; Bryant CJ; Caddye E; East P; Caunt CJ; Keyse SM
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18267-72. PubMed ID: 25489104
[TBL] [Abstract][Full Text] [Related]
18. MKP-2: out of the DUSP-bin and back into the limelight.
Lawan A; Torrance E; Al-Harthi S; Shweash M; Alnasser S; Neamatallah T; Schroeder J; Plevin R
Biochem Soc Trans; 2012 Feb; 40(1):235-9. PubMed ID: 22260697
[TBL] [Abstract][Full Text] [Related]
19. Dual-specificity MAP kinase phosphatases as targets of cancer treatment.
Nunes-Xavier C; Romá-Mateo C; Ríos P; Tárrega C; Cejudo-Marín R; Tabernero L; Pulido R
Anticancer Agents Med Chem; 2011 Jan; 11(1):109-32. PubMed ID: 21288197
[TBL] [Abstract][Full Text] [Related]
20. A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs.
Tanoue T; Yamamoto T; Maeda R; Nishida E
J Biol Chem; 2001 Jul; 276(28):26629-39. PubMed ID: 11359773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
